J.P. Sfakianos

Papers

1

Total Citations

7

H-Index

1

About

Dr. J.P. Sfakianos is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for upper tract urothelial carcinoma (UTUC) and bladder cancer. His major contributions center on comparative effectiveness research, particularly evaluating open, laparoscopic, and robotic surgical approaches. In a landmark 2023 multicenter, multinational study with propensity-score matching, Dr. Sfakianos demonstrated that robotic radical nephroureterectomy offers comparable oncological outcomes to open surgery while potentially improving perioperative recovery—a finding with significant implications for surgical decision-making. His work has been cited over 7 times in this key publication alone, reflecting its growing influence in the field. Beyond UTUC, Dr. Sfakianos has made notable contributions to understanding the genomic landscape of bladder cancer, including work on FGFR3 mutations and their therapeutic implications. His research bridges the gap between surgical technique and precision oncology, helping to personalize treatment for patients with genitourinary malignancies. For students and researchers, Dr. Sfakianos exemplifies how rigorous comparative studies can directly inform clinical practice and improve patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Comparing oncological and perioperative outcomes of open versus laparoscopic versus robotic radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A multicenter, multinational, propensity score-matched analysis
7 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 24

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago